Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

Awareness of Infantile Hemangioma

What could be more frightening than bringing your newborn baby home in perfect health, then noticing a bright red tumor-like growth on your baby’s skin? What’s more frustrating than seeking multiple medical opinions, only to be told “just watch and wait”? Infantile Hemangioma is a common benign growth that affects millions of newborn babies. A small percentage can be dangerous to a child’s health, and many more can leave permanent tissue damage if untreated. Until recently, awareness of Infantile Hemangioma was minimal, and available treatments carried significant side effects. A truly groundbreaking treatment has changed the landscape of Pediatric Dermatology. Leading experts like Dr. Ana Duarte, Founder of the Children’s Skin Center and Head of Dermatology at Miami Children’s Hospital, have called this drug “a true game-changer”. Watch and see how it is changing the lives of families living with Infantile Hemangioma.

On this episode of The Balancing Act, we’re discussing all things health and science with a side dish of QuickBytes. BioTE Medical is a leader in Precision and Preventive Medicine. They create patient-centric strategies that optimize hormones for women and men. Amazon Future Engineer is a comprehensive childhood-to-career program aimed at increasing access to computer […]

Since 1925, Lewis Bake Shop has been rising to the challenge of baking the very best products with a forward-thinking passion for growth and innovation. The result: Bread for the way you live™.

BioTE Medical is a leader in Precision and Preventive Medicine. They create patient-centric strategies that optimize hormones for women and men.

Comments

comments